e-learning
resources
London 2016
Tuesday, 06.09.2016
Mechanisms of disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Deriving type II alveolar cells from pluripotent stem cells to produce a novel model of alpha-1 antitrypsin deficiency pathogenesis
Killian Hurley (Dublin 3, Ireland), Killian Hurley, Anjali Jacob, Dylan Thomas, Finn Hawkins, Andrew Wilson, Darrell Kotton
Source:
International Congress 2016 – Mechanisms of disease
Session:
Mechanisms of disease
Session type:
Poster Discussion
Number:
4659
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Killian Hurley (Dublin 3, Ireland), Killian Hurley, Anjali Jacob, Dylan Thomas, Finn Hawkins, Andrew Wilson, Darrell Kotton. Deriving type II alveolar cells from pluripotent stem cells to produce a novel model of alpha-1 antitrypsin deficiency pathogenesis. Eur Respir J 2016; 48: Suppl. 60, 4659
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
TGFβ-induced epithelial to mesenchymal transition (EMT) as a model of COPD
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016
Induced pluripotent stem cells for generating lung alveolar epithelial cells and modelling respiratory disease
Source: Eur Respir Monogr 2021; 91: 205-221
Year: 2021
Generation of an immortalized functional alveolar epithelial cell line originating from human induced pluripotent stem cells
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016
Human lung mast cells alter asthmatic airway epithelial cell function
Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Year: 2013
Epithelial to mesenchymal transition in basal progenitor epithelial cells cultured from smokers and COPD patients
Source: International Congress 2015 – Airway remodelling: recent developments
Year: 2015
The secretome of induced pluripotent stem cells (iPSC) modulates macrophage phenotype in the fibrotic lung
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Induction of mesenchymal cell phenotypes in lung epithelial cells by adenovirus E1A
Source: Eur Respir J 2006; 28: 1106-1117
Year: 2006
Myeloid derived suppressor cell-like fibrocytes are increased and associated with preserved lung function in COPD
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Altered airway epithelial cell specification in COPD
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015
Regulation of GROα production in human bronchial epithelial cells
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
Identification and characterization of mesenchymal stem cells in the human lung
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
LSC - 2021 - Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids
Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Year: 2021
Chemotaxis of mesenchymal progenitor cells in the murine lung
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015
The capacity of human airway epithelium to regulate T cell proliferation is reduced in asthma
Source: International Congress 2015 – Asthma mechanisms and management
Year: 2015
HDAC inhibitors may regulate EMT and surfactant protein C in human alveolar epithelial cells
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Establishment of alveolar epithelial progenitor cells from the lung with ABCA3 mutations
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
LSC - 2018 - Generation of alveolar epithelial cells from human induced pluripotent stem cells for a model of alveolar wound repair
Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Year: 2018
Interstitial lung disease related surfactant protein-C mutations alter the transcriptome and progenitor cell function of alveolar epithelial cells in mice
Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Year: 2019
ABCA3 mutations disturb lipid homeostasis in alveolar epithelial cells
Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Year: 2013
Differential expression of uPAR in cultured bronchial epithelial cells from asthma patients
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept